Vimarsana
Biggest News Aggregation in the World

Jay Gertz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jay Gertz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jay Gertz Today - Breaking & Trending Today

Estrogen Receptor Mutation Study Suggests Potential Treatments For Endometrial Cancers - Vimarsana News

Estrogen Receptor Mutation Study Suggests Potential Treatments For Endometrial Cancers

Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer.

Study identifies potential new treatment options for people with endometrial cancer - Vimarsana News

Study identifies potential new treatment options for people with endometrial cancer

Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer.

Estrogen receptor mutation study suggests pot - Vimarsana News

Estrogen receptor mutation study suggests pot

Huntsman Cancer Institute researchers studied estrogen receptor mutations and its connections to endometrial cancer. The findings led to the identification of potential personalized treatments for a cancer with limited options.

Ligand Reports First Quarter 2021 Financial Results - Vimarsana News

Ligand Reports First Quarter 2021 Financial Results

Ligand Reports First Quarter 2021 Financial Results Search jobs Conference Call Begins at 4:30 p.m. Eastern Time Today SAN DIEGO--(BUSINESS WIRE)--$LGND#earnings-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2021 and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions. “This year has opened strong for Ligand with solid financial performance and great results from all of our core...